Amfora Inc., a San Francisco, CA-based biotech startup focused on developing crops with enhanced nutritional content, closed a $5M Series A financing.
The round was led by Spruce Capital, co-manager of the MLS Fund II, with participation from The Commonwealth Scientific Industrial Research Organization (CSIRO). In conjunction with the funding, Lindsay Adler, Executive Manager of Global Business Development for CSIRO, will join Amfora’s Board of Directors.
CSIRO also granted to Amfora a worldwide, exclusive license to CSIRO’s proprietary technology to increase energy density in specified forage crops.
The company intends to use the funds to accelerate the development of forage crops for improved human and animal nutrition.
Led by Lloyd M. Kunimoto, President and CEO, Michael Lassner, Chief Science Officer, and Jonathan Burbaum, a Spruce Capital Entrepreneur-in-Residence and Chief Strategy Officer, Amfora leverages biotechnology to develop nutritionally enhanced forage crops to increase protein production efficiency. In addition to increasing the energy density of forage crops, the company intends to build a pipeline of forage products that incorporate multiple approaches to increasing protein production efficiency and crop productivity, as well as develop nutritionally enhanced crops for human nutrition.
FinSMEs
12/04/2017